AR004515A1 -
INJECTABLE COMPOSITIONS CONTAINING BENZMIDAZOLES AS AN ACTIVE AGENT FOR THE TREATMENT OF HELMINTIASIS AND METHODS FOR ITS PREPARATION
- Google Patents
INJECTABLE COMPOSITIONS CONTAINING BENZMIDAZOLES AS AN ACTIVE AGENT FOR THE TREATMENT OF HELMINTIASIS AND METHODS FOR ITS PREPARATION
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microsules Argentina S A De Servicios C I I AfiledCriticalMicrosules Argentina S A De Servicios C I I A
Publication of AR004515A1publicationCriticalpatent/AR004515A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención se refiere a un compuesto antihelmíntico inyectable conteniendo bencimidazol en un vehículo farmacéutico aceptable. Estecompuesto,en medio ácido, que puede ser inyectado a grandes animales en pequeno volumen. Cuandoe s inyectado produce niveles en sangre terapéuticos útiles parael tratamiento de los parásitos gastrointestinales, incluyendo ostertagia.The present invention relates to an injectable anthelmintic compound containing benzimidazole in an acceptable pharmaceutical vehicle. This compound, in an acid medium, which can be injected into large animals in small volumes. When injected it produces useful therapeutic blood levels for the treatment of gastrointestinal parasites, including ostertagia.
ARP960104545A1995-12-211996-09-30
INJECTABLE COMPOSITIONS CONTAINING BENZMIDAZOLES AS AN ACTIVE AGENT FOR THE TREATMENT OF HELMINTIASIS AND METHODS FOR ITS PREPARATION
AR004515A1
(en)
A WATERPROOF FORMULATION THAT ALLOWS THE STABILIZATION OF PEG-INTERFERRED SPOUSES ALFA DURING AND AFTER THE LIOFILIZATION, PROCESS TO PRODUCE A LIOFILIZED POWDER, A LIOFILIZED POWDER, A PROCESS TO PRODUCE A SET-UP OF THE SETTLEMENT MANUFACTURE
USE OF A SELECTED RETINOID COMPONENT BETWEEN THE GROUP FORMED BY ACTIVE RETINOID AGENTS, PRETURSORS OF ACTIVE RETINOID AGENTS AND MIXTURES OF THE SAME, TO PREPARE A PHARMACEUTICAL COMPOSITION